-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Nbux1kLVinzt77hWF/c7PsLRVK+14ZmHM/GKgjOYhVc/2THkqJehESX8dLpJFDjM
 +2v6qyAq0s9elMZRnz+3FA==

<SEC-DOCUMENT>0000012208-07-000022.txt : 20070807
<SEC-HEADER>0000012208-07-000022.hdr.sgml : 20070807
<ACCEPTANCE-DATETIME>20070807162638
ACCESSION NUMBER:		0000012208-07-000022
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20070630
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20070807
DATE AS OF CHANGE:		20070807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO RAD LABORATORIES INC
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07928
		FILM NUMBER:		071031941

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DR
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k2q63007cover.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>UNITED STATES</TITLE>
<META NAME="author" CONTENT="Tom Brida">
<META NAME="date" CONTENT="08/07/2007">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:643.2px"><P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>UNITED STATES</B></P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>FORM 8-K</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="margin:0px" align=center><B>CURRENT REPORT</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>Date of Report: August 7, 2007</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Date of earliest event reported)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="line-height:12px; margin:0px"><BR></P>
<P style="line-height:10.667px; margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>BIO-RAD LABORATORIES, INC.</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Exact name of registrant as specified in its charter)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="line-height:12px; margin:0px"><BR></P>
<P style="margin:0px" align=center><B>Commission File Number: 1-7928</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=360></TD><TD width=7.133></TD><TD width=352.8></TD></TR>
<TR><TD width=360><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD width=352.8><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=360><P style="margin:0px" align=center><B>Delaware</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="margin:0px" align=center><B>94-1381833</B></P>
</TD></TR>
<TR><TD valign=top width=360><P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(State or other jurisdiction of</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>incorporation or organization)</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(I.R.S. Employer</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>Identification No.)</B></P>
</TD></TR>
</TABLE>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="line-height:10.667px; margin:0px; font-size:10.667px">&nbsp;</P>
<P style="margin:0px" align=center><B>1000 Alfred Nobel Dr.</B></P>
<P style="margin:0px" align=center><B>Hercules, California 94547</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Address of principal executive offices, including zip code)</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<P style="margin:0px" align=center><B>(510) 724-7000</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Registrant&#146;s telephone number, including area code)</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="line-height:10.667px; margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=562.733></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=562.733><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=565.6></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=565.6><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=616.267></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=616.267><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=615></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=615><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><B>&nbsp;</B></P>
<P style="margin:0px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=83.333></TD><TD width=285.933></TD></TR>
<TR><TD valign=top width=83.333><P style="margin:0px" align=justify><B>ITEM 2.02</B></P>
</TD><TD valign=top width=285.933><P style="margin:0px"><B>Results of Operations and Financial Condition</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px">On August 7, 2007, Bio-Rad Laboratories, Inc. announced its results of operations and financial condition as of and for the quarter ended June 30, 2007. &nbsp;A copy of the press release is furnished as Exhibit 99.1 to this report.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed to be &#147;filed&#148; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. </P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=83.333></TD><TD width=492.667></TD></TR>
<TR><TD valign=top width=83.333><P style="margin:0px"><B>ITEM 9.01</B></P>
</TD><TD valign=top width=492.667><P style="margin:0px"><B>Financial Statements and Exhibits</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=60></TD><TD width=24></TD><TD width=497.533></TD></TR>
<TR><TD width=60><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=24><P style="margin:0px">&nbsp;</P>
</TD><TD width=497.533><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=60><P style="margin:0px"><B>Exhibit</B></P>
<P style="margin:0px"><B>Number&nbsp;</B></P>
</TD><TD valign=bottom width=24><P style="margin:0px">&nbsp;</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=497.533><P style="margin:0px"><BR></P>
<P style="margin:0px"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin-top:2.2px; margin-bottom:0px" align=right>99.1&nbsp;</P>
</TD><TD valign=bottom width=24><P style="margin-top:2.2px; margin-bottom:0px">&nbsp;</P>
</TD><TD valign=bottom width=497.533><P style="margin-top:2.2px; margin-bottom:0px">Press release of Bio-Rad Laboratories, Inc. dated August 7, 2007</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; page-break-before:always" align=center><B>SIGNATURES</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin:0px">&nbsp;&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=50.867></TD><TD width=136.333></TD><TD width=29.467></TD><TD width=29.467></TD><TD width=4></TD><TD width=253.867></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=257.867 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=257.867 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=287.333 colspan=3><P style="margin:0px">BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=257.867 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="margin:0px">Date:</P>
</TD><TD style="border-bottom:1px solid #000000" width=136.333><P style="margin:0px">August 7, 2007</P>
</TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="margin:0px">By:</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=257.867 colspan=2><P style="margin:0px">&nbsp;/s/ Christine A. Tsingos</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=253.867><P style="margin:0px">Christine A. Tsingos<U> </U></P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=253.867><P style="margin:0px">Vice President, Chief Financial Officer</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=4><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=253.867><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<A NAME="id_11"></A><A NAME="id_12"></A><P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>EXHIBIT INDEX</B></P>
<P style="margin:0px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=34.2></TD><TD width=28.267></TD><TD width=513.533></TD></TR>
<TR><TD width=34.2><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=28.267><P style="margin:0px">&nbsp;</P>
</TD><TD width=513.533><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=34.2><P style="line-height:12px; margin:0px; font-size:9.333px"><B>Exhibit</B></P>
<P style="line-height:12px; margin:0px; font-size:9.333px"><B>Number</B></P>
</TD><TD valign=bottom width=28.267><P style="margin:0px; font-size:9.333px">&nbsp;</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=513.533><P style="line-height:12px; margin:0px; font-size:9.333px"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=34.2><P style="margin:0px">99.1</P>
</TD><TD valign=bottom width=28.267><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=513.533><P style="margin:0px">Press release of Bio-Rad Laboratories, Inc. dated August 7, 2007</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1 CHARTER
<SEQUENCE>2
<FILENAME>exh991063007.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>PART 1 &#8211; FINANCIAL INFORMATION</TITLE>
<META NAME="author" CONTENT="Stephanie Trudrung">
<META NAME="date" CONTENT="08/07/2007">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:604.8px"><P style="line-height:18.667px; margin:0px; font-size:16px" align=right><U>Exhibit 99.1</U></P>
<P style="margin:0px" align=right><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:17.333px; margin:0px; padding-right:43.2px; font-size:14.667px"><B>FOR IMMEDIATE RELEASE</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="line-height:17.333px; margin:0px; font-size:14.667px" align=center><B>BIO-RAD REPORTS SECOND-QUARTER 2007 FINANCIAL RESULTS</B></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px"><B>HERCULES, CA &#150; August 7, 2007</B> &#150; Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced financial results today for the second quarter ended June 30, 2007. </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Second-quarter revenues were $339.1 million in 2007, up 6.7% compared to $317.7 million reported for the second quarter of 2006. On a currency-neutral basis, revenues increased 3.0% compared to the same period last year.<FONT COLOR=#0000FF> </FONT>In the second quarter of 2006, the Company reported one-time additional revenue of $11.7 million resulting from a licensing settlement agreement reached with bioM&#233;rieux. That settlement had a favorable impact on both the second quarter and year-to-date figures for 2006. Excluding revenue gained from the bioM&#233;rieux settlement, revenue growth for the second quarter in 2007 was 10.8% compared to the second quarter of 2006. </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Net income for the quarter was<FONT COLOR=#0000FF> </FONT>$25.7 million compared to<FONT COLOR=#0000FF> </FONT>$32.3 million reported for the same quarter last year. Second-quarter net income for 2007 was $0.96 per share, or $0.95 per share on a fully diluted basis, compared to $1.22 and $1.20, respectively, during the same quarter last year. Net income was approximately the same for the second quarter of 2007 compared to the same quarter in 2006 excluding the net income impact of the 2006 bioM&#233;rieux settlement.</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Year-to-date revenues grew by 5.7% to $661.6 million compared to the same period last year. Normalizing for the impact of currency effects, growth was 1.7%. Year-to-date net income for 2007 was $52.7 million compared to $63.5 million in the same period last year. On a per share basis, year-to-date net income for 2007 was $1.98 per share, or $1.94 per share on a fully diluted basis, or $2.41 and $2.36, respectively, for the first six months of 2006. </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Second-quarter gross margin was 56.0% compared to 58.1% in the same period last year. Gross margin for the second quarter last year was also positively impacted by the agreement reached with bioM&#233;rieux. Year-to-date gross margin was 55.8% compared to 57.5% in the same period in 2006. &nbsp;</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; padding-right:43.2px; font-size:14.667px" align=center>(more)</P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="line-height:17.333px; margin:0px; padding-right:43.2px; font-size:14.667px">Bio-Rad Reports Second-Quarter 2007 Financial Results</P>
<P style="line-height:17.333px; margin:0px; font-size:14.667px">Page 2</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">&#147;At the halfway mark for 2007, we are encouraged by strong results in certain markets,&#148; said Norman Schwartz, Bio-Rad President and Chief Executive Officer. &#147;As the year progresses, we will continue to pursue opportunities to expand the business and improve operational efficiencies. We look forward to DiaMed joining Bio-Rad later this year.&#148; &nbsp;</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:24.667px; margin:0px; font-size:14.667px">Life Science </P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Life Science segment net sales for the quarter were $146.0 million, up 8.6% compared to the same period last year.<FONT COLOR=#0000FF> </FONT>On a currency-neutral basis, segment sales<FONT COLOR=#0000FF> </FONT>increased by 5.2%. Overall performance in this segment benefited from an increase of both sales of the ProteOn<SUP>&#8482;</SUP> XPR36 protein interaction array system as well as the Bio-Plex<SUP>&#174;</SUP> suspension array system and reagents. Sales of process chromatography media, particularly CHT<SUP>&#8482;</SUP> Ceramic Hydroxyapatite were strong as the products continued to gain broad market acceptance. CHT Ceramic Hydroxyapatite is used in the purification stages in the manufacture of a variety of pharmaceuticals and vaccines. Sales results in the Life Science segment were somewhat tempered by continued erosion of BSE (bovine spongiform encephalopathy) testing revenue,<FONT COLOR=#0000FF> </FONT>as both the number of animals tes
ted and the average selling price continues to decline. &nbsp;</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:24.667px; margin:0px; font-size:14.667px">Clinical Diagnostics</P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">The Clinical Diagnostics segment reported net sales of $189.8 million for the quarter,<FONT COLOR=#0000FF> </FONT>up 5.4% </P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">compared to the second quarter last year, or 1.4% excluding currency effects. However, excluding a one-time settlement agreement reached with bioM&#233;rieux in the second quarter last year, net sales were up 12.7%. These results were largely due to continued growth across all product lines, especially in blood virus, autoimmune, and quality control products.<FONT COLOR=#0000FF> </FONT>During the quarter, the Company announced that it had signed a definitive agreement to acquire Switzerland-based DiaMed Holding AG, which develops, manufactures, and markets a complete line of reagents and instruments used in blood typing and screening. In April, the Clinical Diagnostics segment introduced Epstein Barr Virus kits for use on the BioPlex<SUP>&#174;</SUP> 2200 system, a fully-automated multiplex testing system that can generate multiple results from a single patient sample. During the quarter, Bio-Rad signed two multi-year agreements with Quest Diagn
ostics to place BioPlex 2200 systems and autoimmune test reagents as well as HIV test systems and quality controls in their network of reference laboratories nationwide. Also during the quarter, Bio-Rad and Beckman Coulter announced an agreement regarding the continued development and manufacture of immunodiagnostic tests for blood virus and infectious disease.</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; padding-right:43.2px; font-size:14.667px" align=center>(more)</P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="line-height:17.333px; margin:0px; padding-right:43.2px; font-size:14.667px">Bio-Rad Reports Second-Quarter 2007 Financial Results</P>
<P style="line-height:17.333px; margin:0px; font-size:14.667px">Page 3</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Management will discuss these results in a conference call at 2 PM Pacific Time (5 PM Eastern Time) August 7, 2007. Interested parties can access the call by dialing 888-713-4214 (in the US), </P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">or 617-213-4866 (international), access number 74604117. The live webcast can be accessed at <U>http://www.bio-rad.com</U>. A replay of the call will be available at 888-286-8010 (in the US), or 617-801-6888 (international), access number 30053706, for seven days following the call and the webcast can be accessed at <U>http://www.bio-rad.com</U> for 30 days.</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">About Bio-Rad</P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), has remained at the center of scientific discovery for more than 50 years manufacturing and distributing a broad range of products for the life science research and clinical diagnostics markets. The Company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The Company employs over 5,000 people globally and had revenues of nearly $1.3 billion in 2006. For more information, visit www.bio-rad.com. </P>
<P style="margin:0px"><BR></P>
<P style="line-height:17.333px; margin:0px; font-size:14.667px">This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, &#147;believe,&#148; &#147;expect,&#148; &#147;may,&#148; &#147;will,&#148; &#147;intend,&#148; &#147;estimate,&#148; &#147;continue,&#148; or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the &#147;Risk Factors&#148; in the Company&#146;s public reports filed with the Securities and Exchange Commission, including the Company&#146;s Annual Report on Form 10-K for the fiscal year 
ended December 31, 2006, as updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. &nbsp;Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements. </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">For more information contact:</P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Christine Tsingos, Vice President and Chief Financial Officer, or</P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Ron Hutton, Treasurer</P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">Bio-Rad Laboratories, Inc.</P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">510-724-7000</P>
<P style="line-height:21.333px; margin:0px; font-size:14.667px">investor_relations@bio-rad.com </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=right><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=319.333></TD><TD width=74.533></TD><TD width=12></TD><TD width=71.667></TD><TD width=12></TD><TD width=77.667></TD><TD width=12.333></TD><TD width=71></TD></TR>
<TR><TD valign=top width=650.533 colspan=8><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=650.533 colspan=8><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=650.533 colspan=8><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=650.533 colspan=8><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>Condensed Consolidated Statements of Income</P>
</TD></TR>
<TR><TD valign=top width=650.533 colspan=8><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>(In thousands, except per share data)</P>
</TD></TR>
<TR><TD valign=top width=650.533 colspan=8><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=319.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=158.2 colspan=3><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=161 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=319.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=158.2 colspan=3><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>Three Months Ended</P>
<P style="line-height:14.667px; margin:0px; font-size:12px" align=center>June 30,</P>
</TD><TD valign=top width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=161 colspan=3><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>Six Months Ended</P>
<P style="line-height:14.667px; margin:0px; font-size:12px" align=center>June 30,</P>
</TD></TR>
<TR><TD width=319.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>2007</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>2006</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>2007</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>2006</P>
</TD></TR>
<TR><TD width=319.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=74.533><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Net sales</P>
</TD><TD width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;339,114&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;317,747&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;661,622&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;626,085&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-size:12px">Cost of goods sold</P>
</TD><TD style="border-bottom:1px solid #000000" width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>149,123&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>133,085&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>292,250&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>265,895&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Gross profit</P>
</TD><TD width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>189,991&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>184,662&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>369,372&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>360,190&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Selling, general and administrative expense</P>
</TD><TD width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>119,551&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>110,466&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>227,301&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>210,536&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Product research and development expense</P>
</TD><TD width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>34,754&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>30,971&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>67,535&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>59,062&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Interest expense</P>
</TD><TD width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>7,867&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>7,880&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>15,736&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>15,899&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Foreign exchange (gains) losses, net</P>
</TD><TD width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>(398)</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>1,241&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>(670)</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>1,252&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Other (income) expense, net</P>
</TD><TD width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>(7,495)</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>(7,753)</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>(13,681)</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>(12,295)</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Income before taxes</P>
</TD><TD style="border-top:1px solid #000000" width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>35,712&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>41,857&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>73,151&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>85,736&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-size:12px">Provision for income taxes</P>
</TD><TD style="border-bottom:1px solid #000000" width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>10,041&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>9,591&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>20,483&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>22,272&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Net income</P>
</TD><TD style="border-bottom:2.667px double #000000" width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25,671&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32,266&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52,668&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;63,464&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=74.533><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:2.667px double #000000" width=71.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:2.667px double #000000" width=77.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:2.667px double #000000" width=71><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Basic earnings per share:</P>
</TD><TD width=74.533><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-size:12px">Net income</P>
</TD><TD style="border-bottom:2.667px double #000000" width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.96&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.22&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.98&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.41&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-size:12px">Weighted average common shares</P>
</TD><TD style="border-bottom:2.667px double #000000" width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>26,657&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>26,341&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>26,619&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>26,309&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=74.533><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; font-size:12px">Diluted earnings per share:</P>
</TD><TD width=74.533><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-size:12px">Net income</P>
</TD><TD style="border-bottom:2.667px double #000000" width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.95&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.20&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.94&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.36&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-size:12px">Weighted average common shares</P>
</TD><TD style="border-bottom:2.667px double #000000" width=74.533><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>27,164&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>26,900&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.667><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>27,160&nbsp;</P>
</TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>26,865&nbsp;</P>
</TD></TR>
<TR><TD width=319.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=74.533><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; padding-left:-48px; padding-right:-65.333px; font-size:12px; page-break-before:always" align=center>BIO-RAD LABORATORIES, INC</P>
<P style="margin:0px; font-size:12px" align=center>Condensed Consolidated Balance Sheets</P>
<P style="margin:0px; font-size:12px" align=center>(In thousands)</P>
<P style="margin:0px; font-size:12px" align=center>(Unaudited)</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=432.267></TD><TD width=16.867></TD><TD width=75.4></TD><TD width=16.867></TD><TD width=89.8></TD></TR>
<TR><TD valign=top width=432.267><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=75.4><P style="margin:0px; font-size:12px" align=center>June 30,</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=89.8><P style="margin:0px; font-size:12px" align=center>December 30,</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=75.4><P style="margin:0px; font-size:12px" align=center>2007</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=89.8><P style="margin:0px; font-size:12px" align=center>2006</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; font-size:12px">Current assets: </P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=75.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=89.8><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Cash and cash equivalents &nbsp;</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;232,403&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;223,607&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Short-term investments</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>270,463&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>264,473&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Accounts receivable, net </P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>303,266&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>292,970&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Inventories, net </P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>265,185&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>253,045&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Other current assets</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=75.4><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>96,422&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=89.8><P style="margin:0px; font-size:12px" align=right>95,682</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; text-indent:28.8px; font-size:12px">Total current assets </P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>1,167,739&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>1,129,777&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; font-size:12px">Net property, plant and equipment </P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>191,605&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>189,627&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; font-size:12px">Goodwill </P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>121,492&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>119,492&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; font-size:12px">Purchased intangibles, net</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>44,272&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>44,605&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; font-size:12px">Other assets </P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=75.4><P style="margin:0px; font-size:12px" align=right>129,635&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=89.8><P style="margin:0px; font-size:12px" align=right>112,667&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; text-indent:28.8px; font-size:12px">Total assets</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=75.4><P style="margin:0px; font-size:12px" align=right>$ &nbsp;1,654,743&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=89.8><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;1,596,168&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=75.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=89.8><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; font-size:12px">Current liabilities:</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=75.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=89.8><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Notes payable and current maturities of long-term debt</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=75.4><P style="margin:0px; font-size:12px" align=right>4,604&nbsp;</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=89.8><P style="margin:0px; font-size:12px" align=right>3,042&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Accounts payable</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>67,229&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>83,411&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Accrued payroll and employee benefits</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>82,436&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>92,101&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Sales, income and other taxes payable</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>16,683&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>19,949&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; padding-left:19.2px; font-size:12px">Other current liabilities</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=75.4><P style="margin:0px; font-size:12px" align=right>110,897&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=89.8><P style="margin:0px; font-size:12px" align=right>121,030&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; text-indent:28.8px; font-size:12px">Total current liabilities</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>281,849&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>319,533&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; font-size:12px">Long-term debt, net of current maturities</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>426,165&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>425,625&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; font-size:12px">Other long-term liabilities</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=75.4><P style="margin:0px; font-size:12px" align=right>49,930&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=89.8><P style="margin:0px; font-size:12px" align=right>31,472&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; font-size:12px">Stockholders&#146; equity</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=75.4><P style="margin:0px; font-size:12px" align=right>896,799&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=89.8><P style="margin:0px; font-size:12px" align=right>819,538&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="margin:0px; text-indent:38.4px; font-size:12px">Total liabilities and stockholders&#146; equity</P>
</TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=75.4><P style="margin:0px; font-size:12px" align=right>$ &nbsp;1,654,743&nbsp;</P>
</TD><TD width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=89.8><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;1,596,168&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=432.267><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=75.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=89.8><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="line-height:14.667px; margin-top:0px; margin-bottom:6px; font-size:12px">&nbsp;</P>
<P style="margin-top:0px; margin-bottom:6px"><BR>
<BR></P>
<P style="margin-top:0px; margin-bottom:6px; page-break-before:always"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=391.667></TD><TD width=67.333></TD><TD width=16.667></TD><TD width=72></TD></TR>
<TR><TD valign=top width=547.667 colspan=4><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=547.667 colspan=4><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>Condensed Consolidated Statements of Cash Flows</P>
</TD></TR>
<TR><TD valign=top width=547.667 colspan=4><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>(In thousands)</P>
</TD></TR>
<TR><TD valign=top width=547.667 colspan=4><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>(Unaudited) &nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=156 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=156 colspan=3><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>Six Months Ended</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=156 colspan=3><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>June 30,</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=67.333><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>2007</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=72><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>2006</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash flows from operating activities:</P>
</TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Cash received from customers</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;654,230&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;612,996&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Cash paid to suppliers and employees</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(600,174)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(549,519)</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Interest paid</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(15,026)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(15,403)</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Income tax payments</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(17,835)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(2,620)</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Litigation settlement</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(2,082)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(44,960)</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Other operating activities</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>14,318&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>10,998&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Net cash provided by operating activities</P>
</TD><TD style="border-top:1px solid #000000" width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>33,431&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>11,492&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash flows from investing activities:</P>
</TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Cash expenditures, net</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(27,270)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(24,851)</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Receipt of restricted cash</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>36,138&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Other investing activities</P>
</TD><TD style="border-bottom:1px solid #000000" width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(8,712)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(83,043)</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Net cash used in investing activities</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(35,982)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(71,756)</P>
</TD></TR>
<TR><TD width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash flows from financial activities;</P>
</TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Proceeds from issuance of common stock</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>6,162&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>5,467&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Other financing activities</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>3,193&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>1,068&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Net cash provided by financial activities</P>
</TD><TD style="border-top:1px solid #000000" width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>9,355&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>6,535&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Effect of exchange rate changes on cash</P>
</TD><TD style="border-bottom:1px solid #000000" width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>1,992&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>2,659&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Net increase (decrease) in cash and cash equivalents</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>8,796&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(51,070)</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash and cash equivalents at beginning of period</P>
</TD><TD style="border-bottom:1px solid #000000" width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>223,607&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>296,716&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash and cash equivalents at end of period</P>
</TD><TD style="border-bottom:2.667px double #000000" width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;232,403&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;245,646&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=459 colspan=2><P style="line-height:14.667px; margin:0px; font-size:12px">Reconciliation of net income to net cash provided by operating activities:</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin:0px; padding-left:19.2px; font-size:12px">Net income </P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;52,668&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;63,464&nbsp;</P>
</TD></TR>
<TR><TD width=459 colspan=2><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Adjustments to reconcile net income to net cash provided by operating activities:&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Depreciation and amortization</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>28,840&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>26,436&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Changes in working capital</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(44,755)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(46,749)</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Litigation settlement</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(2,082)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(44,960)</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Other</P>
</TD><TD width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(1,240)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>13,301&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Net cash provided by operating activities</P>
</TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=67.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33,431&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=72><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11,492&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=67.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=72><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
